Vancouver, British Columbia, Dec. 09, 2020 (GLOBE NEWSWIRE) -- The Global Intelligent Drug Discovery Market is forecast to be worth USD 3,711.8 Million by 2027, according to a current analysis by Emergen Research. The market is witnessing increased demand due to the rise in the integration of AI in drug discovery, increasing collaboration, and partnerships among market vendors. It also helps to streamline the research and development activities for complex drug discovery and personalized medicines. 

The technology is useful in finding new molecules from the molecule library, identify drug targets, and develop personalized medicines in the industry. AI makes the whole process quick and cost-effective. Several factors are aiding in the growth of the market, such as an increase in the number of people suffering and the flourishing healthcare industry, along with manufacturers' approach towards reducing the overall cost associated with drug development.

Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report@ https://www.emergenresearch.com/request-sample-form/356

A surge in the number of Biopharma companies and a rise in partnerships undertaken by public & private enterprises for research and development activities will boost the demand for the market. Higher investment in the development of healthcare infrastructure by the government, growing awareness regarding the benefits of artificial intelligence in solving complex situations will support the market's demand. Moreover, the strategic approach to lower the cost of drug discovery will also augment the market revenue.

Key Highlights From The Report

• In November 2020, Indivumed launched a groundbreaking artificial intelligence platform to leverage multi-omics data for discoveries in oncology. The company built cutting-edge technology to automate and integrate analytics across oncology bioinformatics to unlock its cast potential.
• The intelligent drug discovery services segment is expected to grow with a significant CAGR. Artificial intelligence is a complex method that requires the implementation of complex, sophisticated algorithms for wide application in precision medicine, drug discovery, and diagnosis.
• The application of deep learning in the pharmaceutical industry has emerged successfully, and its application has gone beyond the prediction of bioactivity and is used in various diverse problems of drug discovery.
• Cardiovascular disease is the number one cause of death in the world. Intelligent drug discovery helps in driving unprecedented productivity enhancements and better outcomes across the value chain from drug discovery to delivery.
• North America held a significant market share due to the increasing demand for AI from the U.S. and the presence of a large number of players in the region. The advanced healthcare infrastructure in the country and growing investment in R&D will also propel the market demand.
• Key participants include IBM Corporation, Microsoft Corporation, Google, NVIDIA Corporation, Cloud Pharmaceuticals, Inc., Atomwise, Inc., Insilico Medicine, Exscientia, Bioage, and Envisagenics, among others.

ORDER NOW (Customized Report Delivered as per Your Specific Requirement)@ https://www.emergenresearch.com/select-license/356

For the purpose of this report, Emergen Research has segmented the Global Intelligent Drug Discovery Market based on offering, technology, application, end-user, and region:

• Offering Outlook (Revenue, USD Billion; 2017-2027)
  • Software
  • Services
• Technology Outlook (Revenue, USD Billion; 2017-2027)
  • Machine Learning
    1. Supervised Learning
    2. Deep Learning
    3. Reinforcement Learning
    4. Unsupervised Learning
  • Other Technologies
• Application Outlook (Revenue, USD Billion; 2017-2027)
  • Neurodegenerative Diseases
  • Metabolic Diseases
  • Immuno-Oncology
  • Cardiovascular Disease
  • Others
• End-User Outlook (Revenue, USD Billion; 2017-2027)
  • Contract Research Organizations
  • Pharmaceutical & Biotechnology Companies
  • Research Centers and Academic & Government Institutes

To identify the key trends in the industry and read full summary click on the link:   https://www.emergenresearch.com/industry-report/intelligent-drug-discovery-market

• Regional Outlook (Revenue, USD Billion; 2017-2027)
  • North America
    1. U.S.
    2. Canada
  • Europe
    1. Germany
    2. U.K.
    3. France
    4. BENELUX
    5. Rest of Europe
  • Asia Pacific
    1. China
    2. Japan
    3. South Korea
    4. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • Middle East & Africa
    1. Saudi Arabia
    2. U.A.E.
    3. Rest of MEA

Take a Look at our Related Reports:

In Silico Drug Discovery Market By Workflow (Discovery, Preclinical Tests, Clinical Trials), By Product (Consultancy as a Service, Software as a Service), By Type of Large Molecule, By End User (Contract Research Organizations, Pharmaceutical Industry), and By Region, Forecasts to 2027

Human Microbiome Modulators Market By Product (Prebiotics and Dietary Supplements, Probiotics and Creams, Drugs), By Application (Infections, Neurological Disorders, Cancers, Dermatological, Gastrointestinal, Metabolic), By Region Forecasts to 2027

Intelligent Drug Discovery Market By Offering (Software, Services), By Technology (Machine Learning, Other Technologies), By Application (Neurodegenerative Diseases, Metabolic Diseases, Immuno-Oncology), By End User (Contract Research Organizations), and By Region, Forecasts to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

Read Full Press Release@ https://www.emergenresearch.com/press-release/global-intelligent-drug-discovery-market